{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:42:27Z","timestamp":1791600147895,"version":"4.3.4"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"21","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Squamous cell carcinoma (SCC) is the most common form of oral cancer. Destruction and invasion of mandibular and maxillary bone frequently occurs and contributes to morbidity and mortality. We hypothesized that the bisphosphonate drug zoledronic acid (ZOL) would inhibit tumor-induced osteolysis and reduce tumor growth and invasion in a murine xenograft model of bone-invasive oral SCC (OSCC) derived from an osteolytic feline OSCC. Luciferase-expressing OSCC cells (SCCF2Luc) were injected into the perimaxillary subgingiva of nude mice, which were then treated with 100 \u03bcg\/kg ZOL or vehicle. ZOL treatment reduced tumor growth and prevented loss of bone volume and surface area but had no effect on tumor invasion. Effects on bone were associated with reduced osteolysis and increased periosteal new bone formation. ZOL-mediated inhibition of tumor-induced osteolysis was characterized by reduced numbers of tartrate-resistant acid phosphatase\u2013positive osteoclasts at the tumor-bone interface, where it was associated with osteoclast vacuolar degeneration. The ratio of eroded to total bone surface was not affected by treatment, arguing that ZOL-mediated inhibition of osteolysis was independent of effects on osteoclast activation or initiation of bone resorption. In summary, our results establish that ZOL can reduce OSCC-induced osteolysis and may be valuable as an adjuvant therapy in OSCC to preserve mandibular and maxillary bone volume and function. Cancer Res; 70(21); 8607\u201316. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-0850","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T22:38:36Z","timestamp":1287527916000},"page":"8607-8616","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Zoledronic Acid Reduces Bone Loss and Tumor Growth in an Orthotopic Xenograft Model of Osteolytic Oral Squamous Cell Carcinoma"],"prefix":"10.1158","volume":"70","author":[{"given":"Chelsea K.","family":"Martin","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian L.","family":"Werbeck","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda K.","family":"Thudi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Lanigan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobie D.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro E.","family":"Toribio","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Rosol","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Veterinary Biosciences and 2Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,10,31]]},"reference":[{"key":"2022061702412090900_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2407-2-37","article-title":"Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000","volume":"2","author":"Shibuya","year":"2002","journal-title":"BMC Cancer"},{"key":"2022061702412090900_bib2","volume-title":"Cancer facts & figures 2009","author":"American Cancer Society","year":"2009"},{"key":"2022061702412090900_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hed.10004","article-title":"Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report","volume":"24","author":"Funk","year":"2002","journal-title":"Head Neck"},{"key":"2022061702412090900_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14219\/jada.archive.2001.0382","article-title":"Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge","volume":"132","author":"Silverman","year":"2001","journal-title":"J Am Dent Assoc"},{"key":"2022061702412090900_bib5","volume-title":"SEER Cancer Statistics Review, 1975\u20132006","author":"Horner"},{"key":"2022061702412090900_bib6","first-page":"468","article-title":"Deep extension from carcinoma arising from the gingiva: CT and MR imaging features","volume":"23","author":"Kimura","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022061702412090900_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1034\/j.1600-0714.2003.00139.x","article-title":"Jaw bone remodeling at the invasion front of gingival squamous cell carcinomas","volume":"32","author":"Ito","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"2022061702412090900_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/MLG.0b013e31816422bb","article-title":"The prognostic impact of extent of bone invasion and extent of bone resection in oral carcinoma","volume":"118","author":"Patel","year":"2008","journal-title":"Laryngoscope"},{"key":"2022061702412090900_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hed.20036","article-title":"The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma","volume":"26","author":"Shaw","year":"2004","journal-title":"Head Neck"},{"key":"2022061702412090900_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor-bone interactions in osteolytic metastases","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"2022061702412090900_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijom.2005.03.008","article-title":"A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma","volume":"34","author":"Shibahara","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2022061702412090900_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2353\/ajpath.2010.090299","article-title":"Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: Significance of interleukin-6 synthesized by stromal cells in response to cancer cells","volume":"176","author":"Kayamori","year":"2010","journal-title":"Am J Pathol"},{"key":"2022061702412090900_bib13","first-page":"663","article-title":"Oral squamous cell carcinomas stimulate osteoclast differentiation","volume":"20","author":"Deyama","year":"2008","journal-title":"Oncol Rep"},{"key":"2022061702412090900_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.21008","article-title":"Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts","volume":"116","author":"Tada","year":"2005","journal-title":"Int J Cancer"},{"key":"2022061702412090900_bib15","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061702412090900_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","article-title":"Rho GTPases and the actin cytoskeleton","volume":"279","author":"Hall","year":"1998","journal-title":"Science"},{"key":"2022061702412090900_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2022061702412090900_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/030098588902600204","article-title":"Feline oral neoplasia: a ten-year survey","volume":"26","author":"Stebbins","year":"1989","journal-title":"Vet Pathol"},{"key":"2022061702412090900_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/9780470690406.ch7","article-title":"Head and neck","volume-title":"Small Animal Oncology","author":"Morris","year":"2001"},{"key":"2022061702412090900_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1476-5810.2006.00096.x","article-title":"Feline head and neck squamous cell carcinoma: A natural model for the human disease and development of a mouse model","volume":"4","author":"Tannehill-Gregg","year":"2006","journal-title":"Vet Comp Oncol"},{"key":"2022061702412090900_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1290\/1071-2690(2001)037<0676:FHANSC>2.0.CO;2","article-title":"Feline head and neck squamous cell carcinoma cell line: Characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-\u03b2","volume":"37","author":"Tannehill-Gregg","year":"2001","journal-title":"In vitro Cell Dev Biol Anim"},{"key":"2022061702412090900_bib22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/pros.20776","article-title":"Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions","volume":"68","author":"Thudi","year":"2008","journal-title":"Prostate"},{"key":"2022061702412090900_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0165-2427(93)90042-3","article-title":"Studies on chicken polyclonal anti-peptide antibodies specific for parathyroid hormone-related protein (1-36)","volume":"35","author":"Rosol","year":"1993","journal-title":"Vet Immunol Immunopathol"},{"key":"2022061702412090900_bib24","first-page":"6015","article-title":"Parathyroid hormone-related protein as a growth regulator of prostate carcinoma","volume":"59","author":"Dougherty","year":"1999","journal-title":"Cancer Res"},{"key":"2022061702412090900_bib25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1097-0142(20001101)89:9<1966::AID-CNCR13>3.0.CO;2-R","article-title":"Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo","volume":"89","author":"Okamoto","year":"2000","journal-title":"Cancer"},{"key":"2022061702412090900_bib26","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1158\/1078-0432.CCR-04-1767","article-title":"Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice","volume":"11","author":"Cui","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061702412090900_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.oraloncology.2006.03.015","article-title":"Establishment of a murine model of bone invasion by oral squamous cell carcinoma","volume":"43","author":"Nomura","year":"2007","journal-title":"Oral Oncol"},{"key":"2022061702412090900_bib28","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/00005537-199811000-00018","article-title":"An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion","volume":"108","author":"Simon","year":"1998","journal-title":"Laryngoscope"},{"key":"2022061702412090900_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0714.2007.00549.x","article-title":"An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma","volume":"36","author":"Henson","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"2022061702412090900_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/path.1603","article-title":"Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-\u03b21","volume":"203","author":"Prime","year":"2004","journal-title":"J Pathol"},{"key":"2022061702412090900_bib31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J Dent Res"},{"key":"2022061702412090900_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"Monkkonen","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2022061702412090900_bib33","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2174\/092986707781389600","article-title":"Zoledronic acid - a multiplicity of anti-cancer action","volume":"14","author":"Yuasa","year":"2007","journal-title":"Curr Med Chem"},{"key":"2022061702412090900_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00223-002-2017-2","article-title":"The role of prenylated small GTP-binding proteins in the regulation of osteoclast function","volume":"72","author":"Coxon","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"2022061702412090900_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2008.09.015","article-title":"Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms","volume":"274","author":"Tada","year":"2009","journal-title":"Cancer Lett"},{"key":"2022061702412090900_bib36","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1158\/1535-7163.MCT-07-0546","article-title":"Zoledronic acid inhibits osteosarcoma growth in an orthotopic model","volume":"6","author":"Dass","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"2022061702412090900_bib37","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ctrv.2008.03.006","article-title":"Antitumor effects of bisphosphonates: promising preclinical evidence","volume":"34","author":"Guise","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"2022061702412090900_bib38","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ctrv.2008.03.008","article-title":"Emerging role of bisphosphonates in the clinic-antitumor activity and prevention of metastasis to bone","volume":"34","author":"Lipton","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"2022061702412090900_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1939-1676.2007.0010.x","article-title":"In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats","volume":"22","author":"Wypij","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2022061702412090900_bib40","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1158\/0008-5472.CAN-06-4508","article-title":"The activity of zoledronic acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation","volume":"67","author":"Peng","year":"2007","journal-title":"Cancer Res"},{"key":"2022061702412090900_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.2009.00160.x","article-title":"Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro","volume":"157","author":"Raikkonen","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2022061702412090900_bib42","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"2022061702412090900_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbrc.2008.01.121","article-title":"PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling","volume":"368","author":"Yamada","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061702412090900_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hed.10008","article-title":"Hypercalcemia associated with parathyroid hormone-related protein at the terminal stage of uncomplicated squamous cell carcinoma in the head and neck region","volume":"24","author":"Fujikawa","year":"2002","journal-title":"Head Neck"},{"key":"2022061702412090900_bib45","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S1470-2045(08)70305-X","article-title":"Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw","volume":"9","author":"Edwards","year":"2008","journal-title":"Lancet Oncol"},{"key":"2022061702412090900_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw: who gets it, and why?","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/21\/8607\/2644859\/8607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/21\/8607\/2644859\/8607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:12:17Z","timestamp":1655446337000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/21\/8607\/561220\/Zoledronic-Acid-Reduces-Bone-Loss-and-Tumor-Growth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,31]]},"references-count":46,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2010,10,31]]},"published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-0850","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22385951","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6501371.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22385951.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6501371","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,31]]}}}